Found: 18
Select item for more details and to access through your institution.
Capturing the Character of Future War.
- Published in:
- Parameters: U.S. Army War College, 2016, v. 46, n. 2, p. 81, doi. 10.55540/0031-1723.2922
- By:
- Publication type:
- Article
Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 diabetes after 26 weeks' treatment: A randomized open label study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2412, doi. 10.1111/dom.15560
- By:
- Publication type:
- Article
Rates of hypoglycaemia are lower in patients treated with insulin degludec/liraglutide ( IDegLira) than with IDeg or insulin glargine, regardless of the hypoglycaemia definition used.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 11, p. 1562, doi. 10.1111/dom.12972
- By:
- Publication type:
- Article
Placebo-controlled, randomized trial of the addition of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes ( AWARD-9).
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 1024, doi. 10.1111/dom.12937
- By:
- Publication type:
- Article
Randomized Study to Characterize Glycemic Control and Short-Term Pulmonary Function in Patients with Type 1 Diabetes Receiving Inhaled Human Insulin (Exubera).
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2007, v. 92, n. 6, p. 2211, doi. 10.1210/jc.2006-0631
- By:
- Publication type:
- Article
Improvement of Glycemic Control, Triglycerides, and HDL Cholesterol Levels With Muraglitazar, a Dual (α/γ) Peroxisome Proliferator-Activated Receptor Activator, in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy
- Published in:
- Diabetes Care, 2006, v. 29, n. 5, p. 1016, doi. 10.2337/dc05-1146
- By:
- Publication type:
- Article
The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial.
- Published in:
- 2003
- By:
- Publication type:
- journal article
The Efficacy and Safety of Dermagraft in Improving the Healing of Chronic Diabetic Foot Ulcers.
- Published in:
- Diabetes Care, 2003, v. 26, n. 6, p. 1701, doi. 10.2337/diacare.26.6.1701
- By:
- Publication type:
- Article
Insulin Degludec 200 Units/mL Is Associated With Lower Injection Frequency and Improved Patient-Reported Outcomes Compared With Insulin Glargine 100 Units/mL in Patients With Type 2 Diabetes Requiring High-Dose Insulin.
- Published in:
- Clinical Diabetes, 2017, v. 35, n. 2, p. 90, doi. 10.2337/cd15-0058
- By:
- Publication type:
- Article
Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2022, v. 327, n. 6, p. 534, doi. 10.1001/jama.2022.0078
- By:
- Publication type:
- Article
Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes: The SWITCH 2 Randomized Clinical Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Semaglutide Added to Basal Insulin in Type 2 Diabetes (SUSTAIN 5): A Randomized, Controlled Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes: The DUAL V Randomized Clinical Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A study of dapagliflozin in patients with type 2 diabetes receiving high doses of insulin plus insulin sensitizers: applicability of a novel insulin-independent treatment.
- Published in:
- 2009
- By:
- Publication type:
- journal article
A Study of Dapagliflozin in Patients With Type 2 Diabetes Receiving High Doses of Insulin Plus Insulin Sensitizers.
- Published in:
- Diabetes Care, 2009, v. 32, n. 9, p. 1656, doi. 10.2337/dc09-0517
- By:
- Publication type:
- Article
23. Insulin Degludec/Liraglutide (IDegLira) Is Superior to Insulin Glargine (IG) in A1c Reduction, Risk of Hypoglycemia, and Weight Change: DUAL V Study (166-OR).
- Published in:
- Nederlands Tijdschrift voor Diabetologie (NTvD), 2015, v. 13, n. 3, p. 78, doi. 10.1007/s12467-015-0044-7
- By:
- Publication type:
- Article
Long-Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older Population.
- Published in:
- Journal of the American Geriatrics Society, 2001, v. 49, n. 8, p. 1025, doi. 10.1046/j.1532-5415.2001.49204.x
- By:
- Publication type:
- Article
80-LB: Tirzepatide, a Dual GIP/GLP-1 Receptor Agonist, Is Effective and Safe When Added to Basal Insulin for Treatment of Type 2 Diabetes (SURPASS-5).
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-80-LB
- By:
- Publication type:
- Article